Statement Regarding the Pre and Post Market Assessment of Durable, Implantable Ventricular Assist Devices in the United States: Executive Summary
Open Access
- 1 December 2012
- journal article
- review article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 94 (6) , e163-e168
- https://doi.org/10.1016/j.athoracsur.2012.09.041
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Postmarketing Surveillance of Medical Devices — Filling in the GapsNew England Journal of Medicine, 2012
- Here We Go Again — Another Failure of Postmarketing Device SurveillanceNew England Journal of Medicine, 2012
- Regulation of Medical Devices in the United States and European UnionNew England Journal of Medicine, 2012
- Medical Devices and Health — Creating a New Regulatory Framework for Moderate-Risk DevicesNew England Journal of Medicine, 2011
- Medical Devices — Balancing Regulation and InnovationNew England Journal of Medicine, 2011
- Third INTERMACS Annual Report: The evolution of destination therapy in the United StatesThe Journal of Heart and Lung Transplantation, 2011
- Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist DeviceNew England Journal of Medicine, 2009
- Progress Versus Precision: Challenges in Clinical Trial Design for Left Ventricular Assist DevicesThe Annals of Thoracic Surgery, 2006
- FDA Perspective on Clinical Trial Design for Cardiovascular DevicesThe Annals of Thoracic Surgery, 2006
- Same Bridge, New Destinations: Rethinking Paradigms for Mechanical Cardiac Support in Heart FailureJournal of the American College of Cardiology, 2006